Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer
NCT ID: NCT00935779
Last Updated: 2009-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2002-10-31
2004-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
NCT04613570
Confocal Endomicroscopy Detection of Gastric Preneoplasia and Neoplasia
NCT01384201
Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases
NCT05115877
Narrow Band Imaging for Gastric Neoplasia
NCT02197351
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
NCT06075199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastric cancer
patients with operable local gastric adenocarcinoma were studied
No interventions assigned to this group
Control group
patients operated on for benign diseases served as controls, randomly selected among patients with chronic gastro-esophageal reflux disease who were considered good candidates for antireflux surgery and properly matched in sex and age to study group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* previous open or blunt abdominal trauma
* history of inflammatory bowel disease or Typhoid Fever, Gallstone disease, chemotherapy or radiotherapy, or any other abdominal condition that could alter peritoneal integrity.
* All other gastric malignancies such as lymphomas, GIST, carcinoids
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital Clinico, Universidad de Chile
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricio Burdiles, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Surgery, Clinical Hospital, University of Chile
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery, Clinical Hospital, University of Chile
Santiago, Santiago Metropolitan, Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OAIC 043/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.